Manages 2.1B across all GBUs (GenMed, Specialty Care, Vaccines) as a key contributor with 50 direct reporting lines across the globe.
Develops, evolves, and deploys the overall strategy on Raw Materials category maximizing value for Industrial Affairs Procurement Directs, Global Business Units and partnering closely with R&D / Drug Development.